ArticleCureus2026
Cranial Neuropathies Associated With Pediatric Brain Tumors: Evaluation of Pediatric Otolaryngology Referral Patterns and Interventions.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Otolaryngologists play a crucial role in managing cranial nerve (CN) deficits in pediatric brain tumors. This study aims to determine rates of persistent cranial neuropathy and associated otolaryngology referral. Methods A total of 109 pediatric patients with primary intracranial neoplasms and documented CN deficits were retrospectively identified. Outcomes of interest included CN deficit, otolaryngology referral, recovery status, and surgical interventions. Variables were analyzed using chi-square and Fisher's exact tests. Results Cranial neuropathies persisted in 69 (63.3%) patients, the majority with posterior fossa tumors. Common deficits included facial weakness (N = 62, 56.9%), ophthalmoplegia (N = 59, 54.1%), vocal fold paresis (N = 11, 10.1%), dysphagia (N = 11, 10.1%), hearing loss (N = 9, 8.3%), and trigeminal neuropathy (N = 7, 6.4%). Twenty-two (20.2%) patients were referred to otolaryngology. Referred patients were significantly less likely to have achieved full recovery (X² = 5.53, p = 0.02) and more likely to undergo corrective intervention (X² = 15.88, p < 0.01). Vocal fold paresis, dysphagia, and hearing loss were each associated with referral (p < 0.01), whereas facial neuropathy, ophthalmoplegia, and trigeminal neuropathy were not. Notably, 51 of 87 (58.6%) non-referred patients demonstrated no recovery of their cranial neuropathy. Conclusions Despite high rates of persistent cranial neuropathies among pediatric patients with intracranial neoplasms, otolaryngology referrals remain notably infrequent, particularly for facial paralysis. Earlier and more systematic referrals may represent a meaningful opportunity to improve functional outcomes through earlier and timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.